| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Aug 20, 2026 |
AMGEN Inc.
AMGN
|
BUY |
$457.00
Est. +3%
|
$442.36 | $447.01 |
Precision Hit (±3%)
|
$403.04
-8.9%
|
| Jul 28, 2026 |
Teva- Pharmaceutical Industries Ltd. - ADR
TEVA
|
BUY |
$44.00
Est. +42%
|
$31.08 | $40.79 |
Pending
|
$39.53
+27.2%
|
| Jul 28, 2026 |
Alkermes plc
ALKS
|
BUY |
$65.00
Est. +23%
|
$52.73 | $52.51 |
Pending
|
$41.75
-20.8%
|
| May 08, 2026 |
Definium Therapeutics, Inc.
DFTX
|
BUY |
$48.00
Est. +107%
|
$23.20 | $49.70 |
Target Met
|
$37.40
+61.2%
|
| Mar 04, 2026 |
Teva- Pharmaceutical Industries Ltd. - ADR
TEVA
|
BUY |
$41.00
Est. +26%
|
$32.64 | $40.79 |
Bullseye Hit (±1%)
|
$39.53
+21.1%
|
| Dec 10, 2025 |
Jazz Pharmaceuticals plc
JAZZ
|
BUY |
$219.00
Est. +35%
|
$162.26 | $266.38 |
Target Met
|
$235.67
+45.2%
|
| Nov 14, 2025 |
AMGEN Inc.
AMGN
|
BUY |
$381.00
Est. +15%
|
$332.43 | $447.01 |
Target Met
|
$403.04
+21.2%
|
| Nov 05, 2025 |
Abbvie Inc
ABBV
|
BUY |
$289.00
Est. +35%
|
$213.57 | $269.39 |
Pending
|
$262.82
+23.1%
|
| Oct 27, 2025 |
Organon & Co.
OGN
|
SELL |
$5.00
Est. +30%
|
$7.13 | $5.69 (Low) |
Pending
|
$13.72
-92.4%
|
| Oct 23, 2025 |
Alkermes plc
ALKS
|
BUY |
$45.00
Est. +45%
|
$31.09 | $55.67 |
Target Met
|
$41.75
+34.3%
|
| Aug 08, 2025 |
ANI Pharmaceuticals Inc
ANIP
|
BUY |
$94.00
Est. +16%
|
$81.13 | $99.50 |
Target Met
|
$72.18
-11.0%
|
| May 15, 2025 |
Organon & Co.
OGN
|
BUY |
$18.00
Est. +105%
|
$8.77 | $13.44 |
Miss
|
$13.72
+56.4%
|
| Apr 22, 2025 |
Bristol-Myers Squibb Co.
BMY
|
BUY |
$65.00
Est. +30%
|
$49.82 | $62.89 |
Miss
|
$61.15
+22.7%
|
| Mar 21, 2025 |
Amphastar Pharmaceuticals Inc
AMPH
|
BUY |
$32.00
Est. +13%
|
$28.29 | $31.26 |
Precision Hit (±3%)
|
$25.43
-10.1%
|
| Feb 04, 2025 |
Collegium Pharmaceutical Inc
COLL
|
BUY |
$36.00
Est. +16%
|
$30.93 | $50.79 |
Target Met
|
$22.02
-28.8%
|
| Jan 14, 2025 |
Intra-Cellular Therapies Inc
ITCI
|
BUY |
$132.00
Est. +59%
|
$83.23 | $131.98 |
Bullseye Hit (±1%)
|
$131.87
+58.4%
|
| Dec 05, 2024 |
Alkermes plc
ALKS
|
BUY |
$37.00
Est. +18%
|
$31.25 | $36.45 |
Precision Hit (±3%)
|
$41.75
+33.6%
|
| Nov 13, 2024 |
OptiNose Inc
OPTN
|
BUY |
$1.00
Est. +12%
|
$0.89 | $9.74 |
Target Met
|
$9.60
+978.7%
|
| Nov 11, 2024 |
Amneal Pharmaceuticals Inc - Ordinary Shares - Class A
AMRX
|
BUY |
$11.00
Est. +33%
|
$8.29 | $12.09 |
Target Met
|
$20.30
+144.9%
|
| Nov 07, 2024 |
Pacira BioSciences Inc
PCRX
|
SELL |
$12.00
Est. +31%
|
$17.37 | $16.10 (Low) |
Miss
|
$25.21
-45.1%
|
| Oct 11, 2024 |
Indivior Plc
INDV
|
BUY |
$15.00
Est. +97%
|
$7.61 | $25.10 |
Target Met
|
$35.71
+369.3%
|
| Sep 13, 2024 |
Indivior Plc
INDV
|
BUY |
$22.00
Est. +129%
|
$9.62 | $25.10 |
Target Met
|
$35.71
+271.2%
|
| Sep 11, 2024 |
Supernus Pharmaceuticals Inc
SUPN
|
BUY |
$36.00
Est. +7%
|
$33.49 | $46.79 |
Target Met
|
$42.38
+26.5%
|
| Sep 05, 2024 |
Intra-Cellular Therapies Inc
ITCI
|
BUY |
$92.00
Est. +27%
|
$72.42 | $131.98 |
Target Met
|
$131.87
+82.1%
|
| Aug 29, 2024 |
Neurocrine Biosciences, Inc.
NBIX
|
BUY |
$159.00
Est. +24%
|
$128.43 | $154.61 |
Precision Hit (±3%)
|
$143.18
+11.5%
|
| Aug 28, 2024 |
Teva- Pharmaceutical Industries Ltd. - ADR
TEVA
|
BUY |
$23.00
Est. +24%
|
$18.62 | $22.80 |
Bullseye Hit (±1%)
|
$39.53
+112.3%
|
| Aug 09, 2024 |
Collegium Pharmaceutical Inc
COLL
|
BUY |
$37.00
Est. +7%
|
$34.63 | $42.29 |
Target Met
|
$22.02
-36.4%
|
| Aug 08, 2024 |
Amphastar Pharmaceuticals Inc
AMPH
|
BUY |
$66.00
Est. +52%
|
$43.31 | $53.96 |
Miss
|
$25.43
-41.3%
|
| Jul 30, 2024 |
Corcept Therapeutics Inc
CORT
|
BUY |
$38.00
Est. +5%
|
$36.12 | $117.33 |
Target Met
|
$116.23
+221.8%
|
| Jun 10, 2024 |
Corcept Therapeutics Inc
CORT
|
BUY |
$35.00
Est. +11%
|
$31.51 | $117.33 |
Target Met
|
$116.23
+268.9%
|
| May 28, 2024 |
Axsome Therapeutics Inc
AXSM
|
BUY |
$115.00
Est. +53%
|
$75.19 | $139.13 |
Target Met
|
$179.25
+138.4%
|
| May 24, 2024 |
Supernus Pharmaceuticals Inc
SUPN
|
BUY |
$41.00
Est. +47%
|
$27.85 | $40.28 |
Precision Hit (±3%)
|
$42.38
+52.2%
|
| May 23, 2024 |
Amphastar Pharmaceuticals Inc
AMPH
|
BUY |
$71.00
Est. +64%
|
$43.31 | $53.96 |
Miss
|
$25.43
-41.3%
|
| May 22, 2024 |
Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A
IRWD
|
BUY |
$18.00
Est. +164%
|
$6.82 | $7.11 |
Miss
|
$3.64
-46.6%
|
| May 21, 2024 |
Pacira BioSciences Inc
PCRX
|
BUY |
$42.00
Est. +37%
|
$30.68 | $27.64 |
Miss
|
$25.21
-17.8%
|
| May 13, 2024 |
Teva- Pharmaceutical Industries Ltd. - ADR
TEVA
|
BUY |
$20.00
Est. +18%
|
$16.90 | $22.80 |
Target Met
|
$39.53
+133.9%
|
| May 10, 2024 |
Collegium Pharmaceutical Inc
COLL
|
BUY |
$39.00
Est. +18%
|
$33.11 | $42.29 |
Target Met
|
$22.02
-33.5%
|
| May 10, 2024 |
Xeris Biopharma Holdings Inc
XERS
|
BUY |
$3.00
Est. +62%
|
$1.85 | $6.07 |
Target Met
|
$9.08
+390.8%
|
| May 10, 2024 |
Revance Therapeutics Inc
RVNC
|
BUY |
$11.00
Est. +194%
|
$3.74 | $6.65 |
Miss
|
$3.65
-2.4%
|
| Apr 29, 2024 |
Bausch Health Companies Inc
BHC
|
BUY |
$9.00
Est. +3%
|
$8.78 | $9.85 |
Target Met
|
$5.80
-33.9%
|
| Apr 29, 2024 |
Organon & Co.
OGN
|
BUY |
$24.00
Est. +27%
|
$18.85 | $23.10 |
Miss
|
$13.72
-27.2%
|
| Apr 11, 2024 |
Aquestive Therapeutics Inc
AQST
|
BUY |
$10.00
Est. +146%
|
$4.07 | $5.80 |
Miss
|
$4.55
+11.8%
|
| Mar 28, 2024 |
Viatris Inc
VTRS
|
BUY |
$13.00
Est. +10%
|
$11.83 | $13.55 |
Target Met
|
$17.60
+48.8%
|
| Mar 21, 2024 |
Amneal Pharmaceuticals Inc - Ordinary Shares - Class A
AMRX
|
BUY |
$8.00
Est. +27%
|
$6.29 | $9.47 |
Target Met
|
$20.30
+222.7%
|
| Mar 20, 2024 |
Jazz Pharmaceuticals plc
JAZZ
|
BUY |
$188.00
Est. +51%
|
$124.79 | $148.14 |
Miss
|
$235.67
+88.9%
|
| Feb 12, 2024 |
Teva- Pharmaceutical Industries Ltd. - ADR
TEVA
|
BUY |
$19.00
Est. +58%
|
$12.01 | $22.80 |
Target Met
|
$39.53
+229.1%
|
| Jun 26, 2023 |
Organon & Co.
OGN
|
BUY |
$34.00
Est. +67%
|
$20.37 | - | - |
$13.72
-32.6%
|
| Jun 26, 2023 |
Viatris Inc
VTRS
|
BUY |
$10.00
Est. +2%
|
$9.84 | - | - |
$17.60
+78.9%
|
| Nov 02, 2022 |
Neurocrine Biosciences, Inc.
NBIX
|
SELL |
$103.00
Est. +14%
|
$119.36 | - | - |
$143.18
-20.0%
|
| Jun 20, 2022 |
Jazz Pharmaceuticals plc
JAZZ
|
BUY |
$193.00
Est. +35%
|
$142.91 | - | - |
$235.67
+64.9%
|
| Jun 13, 2022 |
OptiNose Inc
OPTN
|
BUY |
$4.00
Est. +53%
|
$2.62 | $64.50 |
Target Met
|
$9.60
+266.4%
|
| Apr 22, 2022 |
Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A
IRWD
|
BUY |
$16.00
Est. +31%
|
$12.18 | - | - |
$3.64
-70.1%
|
| Mar 12, 2022 |
Amphastar Pharmaceuticals Inc
AMPH
|
BUY |
$35.00
Est. +2%
|
$34.30 | - | - |
$25.43
-25.9%
|